Parish LC |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group. |
1993 |
Int. J. Dermatol. |
pmid:8340194
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Schmidt T et al. |
Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8288505
|
Ji B et al. |
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. |
1993 |
J. Infect. Dis. |
pmid:8257487
|
Scaglione F et al. |
The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin. |
1993 |
J. Antimicrob. Chemother. |
pmid:8262876
|
Watanabe Y et al. |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. |
1993 |
J. Antibiot. |
pmid:8501007
|
Roig J et al. |
Treatment of Legionnaires' disease. Current recommendations. |
1993 |
Drugs |
pmid:7691508
|
Lonks JR and Medeiros AA |
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239578
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Graham DY et al. |
Clarithromycin for the eradication of Helicobacter pylori. |
1993 |
J. Clin. Gastroenterol. |
pmid:8331260
|
Esvant H et al. |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. |
1993 |
Presse Med |
pmid:8337221
|
Lederer J et al. |
Clarithromycin treatment of posttraumatic Mycobacterium fortuitum wound infection. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8414785
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Goldstein EJ and Citron DM |
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390810
|
Watanabe Y et al. |
Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. |
1993 |
J. Antibiot. |
pmid:8360112
|